The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.
about
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraceptionHormonal contraceptives for contraception in overweight or obese womenHormonal contraceptives for contraception in overweight or obese womenContraceptive failure in the United StatesHormonal contraceptives for contraception in overweight or obese womenContraceptive efficacy and tolerability of ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled studyExtended regimen combined oral contraception: A review of evolving concepts and acceptance by women and cliniciansNew low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control.The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μgAn update on new orally administered contraceptives for women.Characterisation of the pharmacokinetics of ethinylestradiol and drospirenone in extended-cycle regimens: population pharmacokinetic analysis from a randomised Phase III study.The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?New regimens with combined oral contraceptive pills--moving away from traditional 21/7 cycles.Extended and continuous combined contraceptive regimens for menstrual suppression.Extended regimens of combined hormonal contraception to reduce symptoms related to withdrawal bleeding and the hormone-free interval: a systematic review of randomised and observational studies.A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
P2860
Q24194774-1DC2AEF5-7C30-4791-9B4F-CA9349FDC781Q24197670-C71D2AB6-6A5D-4A67-9CC0-85E05D842141Q24234234-CE61DA5A-CC50-45ED-A9CD-0C412075418AQ24630988-D5D55B30-F122-4D5A-B4BB-7877C56AD112Q26470396-D7E6C3F0-70B6-4588-A541-8DF1CEDB1A08Q28384507-D2FF6F41-0FB2-48C8-B577-5C83EE2D1B5CQ28392784-4BB73E5F-D1F3-45F3-987B-D2A2ABBFAB33Q34272169-387516D4-3676-4053-AE28-D5DEDF4ECBC0Q34345598-7F30A9A4-DDF5-4487-B6C3-9BFBA8AC14D0Q34499804-D034E647-87A7-4517-9C43-45EF41A57D14Q36785991-1383EC6C-695A-4C43-A4D2-280C2304F535Q37227518-B416007E-8D5E-4DF0-9C92-861CF3A2CA6FQ37810974-8FAB5C5C-F2AD-4A31-B47E-23010177CA94Q38065342-DC504224-0F79-4100-B473-F1F6015B54B4Q38223794-D591555D-A6A5-4604-9A32-A6C36F55114AQ51101026-E90A0170-7198-4592-BDB0-7C420B104160
P2860
The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@en
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@nl
type
label
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@en
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@nl
prefLabel
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@en
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@nl
P2093
P1433
P1476
The efficacy and safety of a l ...... continuous ethinyl estradiol.
@en
P2093
Kathleen Z Reape
Marya Margolis
Robin Kroll
P356
10.1016/J.CONTRACEPTION.2009.07.003
P577
2010-01-01T00:00:00Z